Mirvetuximab Biosimilar (FOLR1 / FRA Reference Antibody)
Mirvetuximab (M9346A) is an anti-FOLR1 (folate receptor 1) monoclonal antibody. Mirvetuximab is the antibody moiety of novel folate receptor alpha (FRα) -targeting ADC (Mirvetuximab soravtansine) . Mirvetuximab soravtansine can be used in ovarian and other FRα-positive cancer research.
Product Specifications
Target
Mirvetuximab Biosimilar (Anti-FOLR1 / FRA Reference Antibody)
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Neuroscience
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040679-100 1x 100 µL
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470994-100 1x 100 µL
TNF alpha (J2D10), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400181-500 1x 500 µL
CD59 (heavy chain of Protectin) (BRA-10G), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040757-100 1x 100 µL
Cytokeratin 7 (K72.7), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941266-100 1x 100 µL
Cytokeratin 8 (KRT8) (B22.1), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 